|
US2020347038A1
|
|
Quinolines that modulate serca and their use for treating disease
|
|
US2020190077A1
|
|
Neuroprotective hydrazides
|
|
US2020188706A1
|
|
Neuroprotective quinoline sulfonamides
|
|
US2020190078A1
|
|
Neuroprotective aminothiazoles
|
|
US2020039939A1
|
|
Quinoline amines useful as cytoprotective agents
|
|
US2019337899A1
|
|
Quinoline sulfonamides useful to treat disease
|
|
US10730843B1
|
|
Quinoxalines useful as cytoprotective agents
|
|
US2019330156A1
|
|
Quinolines as cytoprotective agents
|
|
US2019375737A1
|
|
Quinoline alkenes as cytoprotective agents
|
|
US2019375741A1
|
|
Quinoline oxadiazoles as cytoprotective agents
|
|
US2019151303A1
|
|
Quinolines that modulate SERCA and their use for treating disease
|
|
US2017231973A1
|
|
Quinoline containing compounds and their use for treating endoplasmic reticulum stress-related diseases
|
|
US2017151225A1
|
|
Quinoline derivatives and their use for treating endoplasmic reticulum stress-related diseases and disorders
|
